论文部分内容阅读
目的:探讨体液细胞学检查在临床中的应用价值。方法:选择我院2013年4月-2015年4月在我院行体液细胞学检查的胸腹水患者255例,所有患者均接受体液细胞学检查,回顾性分析患者检查结果和临床表现,就体液细胞学检查在临床中的应用价值展开研究。结果:255例患者检查炎症性渗出液134例,其中胸水109例、腹水25例,与术后病理证实,诊断符合率98.53%。漏出液76例,其中胸水6例、腹水70例,诊断符合率98.70%;肿瘤性渗出液42例,其中胸水32例、腹水10例,诊断符合率100%。另外,42例肿瘤渗出液中15例无其他特殊检查提示时,由细胞学检查首先明确确诊,占肿瘤渗出液35.71%。结论:体液细胞学检查能够准确鉴别出患者胸腹水情况,方法简单、便于推广,是临床上诊断胸腹水患者的首选检查方式。
Objective: To investigate the value of humoral cytology in clinical application. Methods: A total of 255 patients with pleural effusion and ascites were selected from our hospital from April 2013 to April 2015. All patients underwent cytological examination. The results and clinical manifestations of the patients were retrospectively analyzed. Cytological examination in the clinical application of the value of research. Results: A total of 134 cases of inflammatory exudate were examined in 255 patients, including 109 cases of pleural effusion and 25 cases of ascites. The coincidence rate was 98.53%. The leakage of fluid in 76 cases, of which 6 cases of pleural effusion, ascites 70 cases, the diagnostic coincidence rate was 98.70%; 42 cases of tumor effusion, pleural effusion in 32 cases, ascites in 10 cases, the diagnostic coincidence rate of 100%. In addition, 42 cases of tumor exudate in 15 cases without other special examination prompts, the first clear diagnosis by cytology, accounting for 35.71% of the tumor exudate. Conclusion: HCC can accurately identify the pleural and ascitic fluid in patients. The method is simple and easy to popularize. It is the first choice for the diagnosis of patients with pleural effusion and ascites.